Tag: drug royalties
What Goes Up Is Staying Up.
Posted by Paul Topping | Apr 9, 2019 | Blog, News | 0 |
Dr. Kilpatrick Provides Guidance on Corridor Valua...
Posted by Greenfield Advisors | Mar 7, 2019 | Blog, Our Work, Publications | 0 |
Greenfield Advisor’s Board Chair, Dr. John A...
Posted by Greenfield Advisors | Dec 7, 2018 | Blog, News, Press Releases | 0 |
What an Election Year Means for House Prices
Posted by Holly Wharton | Mar 1, 2016 | Blog, News | 2 |
The Marketplace for Pharmaceutical, Medical Device, and Diagnostic Royalties
by Greenfield Advisors | Mar 29, 2016 | Blog, News | 0 |
Without a doubt, one of the fastest growing private equity markets in the last decade has been the...
Read MoreGreenfield Advisors Launches Pharmaceutical and Medical Royalty Valuation Practice
by Greenfield Advisors | Jan 13, 2016 | News, Press Releases | 0 |
CARTERSVILLE, GA and SEATTLE, WA, JANUARY 13, 2016 – Greenfield Advisors now provides expert medical royalty valuation. The financial and real estate consulting firm saw a need for such services after meeting with several...
Read MoreValuation of Drug Royalties
by Greenfield Advisors | Dec 8, 2015 | Blog, News | 0 |
Drug royalties are the royalties paid primarily by pharmaceutical companies to academic...
Read More
Recent Comments